Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q2 2015 filing in brief

In its Q2 2015 13F, filed August 13, 2015, Baupost Group reported $6.0B across 32 US positions. The largest: LNG (17.7%), VSAT (11.6%), PXDEUR (9.4%), EBAY (9.3%), MU (6.2%). In the quarter it opened 5 positions, sold out of 1, added to 7 and trimmed 5; positions opened and sold out came to 2.4% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Aug 13, 2015

  • 5 New
  • 7 Added
  • 5 Trimmed
  • 1 Exited

32 positions at June 30, 2015. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$1.1B15.4M17.74%+11.3%Added
2VSATVIASAT INC$695M11.5M11.59%0.0%Held
3PXDEURPIONEER NAT RES CO$564M4.1M9.40%+28.4%Added
4EBAYEBAY INC$561M9.3M9.35%0.0%Held
5MUMICRON TECHNOLOGY INC$371M19.7M6.19%0.0%Held
6—THERAVANCE INC$358M19.8M5.97%0.0%Held
7PBFPBF ENERGY INC$313M11.0M5.22%+27.3%Added
8ARANTERO RES CORP$276M8.0M4.59%−14.2%Trimmed
9—KERYX BIOPHARMACEUTICALS INC$257M25.8M4.29%+15.2%Added
10ATRAGBXATARA BIOTHERAPEUTICS INC$254M4.8M4.23%+1.0%Held
11—FORWARD PHARMA A/S$204M5.4M3.40%0.0%Held
12—SUNEDISON SEMICONDUCTOR LTD$143M8.3M2.39%+5.1%Added
13VRTVEURVERITIV CORP$90M2.5M1.51%+9.1%Added
14—THERAVANCE BIOPHARMA INC$84M6.4M1.39%+0.8%Held
15OCN2EUROCWEN FINL CORP$78M7.7M1.30%−2.3%Trimmed
16—CITIGROUP INC$76M102.6M1.27%−0.1%Held
17NGNOVAGOLD RES INC$74M21.7M1.24%0.0%Held
18—CHIPMOS TECH BERMUDA LTD$72M3.3M1.20%0.0%Held
19—FRONTIER COMMUNICATIONS CORP$67M13.5M1.11%—New
20—KLX INC$66M1.5M1.10%0.0%Held
21—BELLATRIX EXPLORATION LTD$51M21.8M0.85%0.0%Held
22—KOSMOS ENERGY LTD$51M6.0M0.84%−17.2%Trimmed
23INVA 2.125 01/15/23THERAVANCE INC$46M48.2M0.76%0.0%Held
24PRTKEURPARATEK PHARMACEUTICALS INC$40M1.5M0.66%−11.0%Trimmed
25—AMERICAN INTL GROUP INC$35M1.3M0.58%+0.3%Held
26FTR 11.125 06/29/18 AFRONTIER COMMUNICATIONS CORP$32M325.0K0.54%—New
27KIN1USDKINDRED BIOSCIENCES INC$21M3.0M0.34%0.0%Held
28—BIOTIE THERAPIES OYJ$17M869.6K0.29%—New
29—ALLIANCE ONE INTL INC$15M638.4K0.25%—New
30ALDWUSDALON USA PARTNERS LP$13M629.2K0.22%−34.1%Trimmed
31SNSANCHEZ ENERGY CORP$6M619.5K0.10%—New
32—NOVACOPPER INC$4M10.6M0.07%+76.5%Added
1 exited position

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—ALLIANCE ONE INTL INC$7M6.4M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.